These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 25583392)

  • 21. Determination of appendicular muscle mass by dual energy X-ray absorptiometry method in women with sarcopenia and Alzheimer's disease.
    Gillette-Guyonnet S; Nourhashemi F; Andrieu S; de Glisezinski I; Grandjean H; Rolland Y; Riviere D; Vellas B
    J Nutr Health Aging; 2000; 4(3):165-9. PubMed ID: 10936904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
    Ahlskog JE; Uitti RJ; Low PA; Tyce GM; Nickander KK; Petersen RC; Kokmen E
    Mov Disord; 1995 Sep; 10(5):566-73. PubMed ID: 8552107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopa-responsive, nonprogressive juvenile parkinsonism: report of a case.
    Rajput A; Kishore A; Snow B; Bolton CF; Rajput AH
    Mov Disord; 1997 May; 12(3):453-6. PubMed ID: 9159748
    [No Abstract]   [Full Text] [Related]  

  • 24. Striatal denervation pattern predicts levodopa effects on sequence learning in Parkinson's disease.
    Kwak Y; Bohnen NI; Müller ML; Dayalu P; Seidler RD
    J Mot Behav; 2013; 45(5):423-9. PubMed ID: 23971968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anterior horn syndrome (spinal muscular atrophy) in Waldenström's disease].
    Kiehl U; Wünsch H
    Z Arztl Fortbild (Jena); 1984; 78(22):963-4. PubMed ID: 6442068
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemiatrophy-hemiparkinsonism and Poland syndrome: A causative or coincidental association?
    Youn J; Gorodetsky C; Lozano AM; Lang AE; Fasano A
    Parkinsonism Relat Disord; 2023 May; 110():105402. PubMed ID: 37084521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.
    Ambrée O; Richter H; Sachser N; Lewejohann L; Dere E; de Souza Silva MA; Herring A; Keyvani K; Paulus W; Schäbitz WR
    Neurobiol Aging; 2009 Aug; 30(8):1192-204. PubMed ID: 18079024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levodopa for the treatment of Parkinson's disease.
    Lewitt PA
    N Engl J Med; 2008 Dec; 359(23):2468-76. PubMed ID: 19052127
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis and treatment of vascular dementia].
    Gold G
    Praxis (Bern 1994); 2004 Aug; 93(33):1311-6. PubMed ID: 15453435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can the syndrome of transient epileptic amnesia be the first feature of Alzheimer's disease?
    Cretin B; Philippi N; Sellal F; Dibitonto L; Martin-Hunyadi C; Blanc F
    Seizure; 2014 Nov; 23(10):918-20. PubMed ID: 25123897
    [No Abstract]   [Full Text] [Related]  

  • 31. Levodopa responsive Parkinsonism in adults with Angelman Syndrome.
    Harbord M
    J Clin Neurosci; 2001 Sep; 8(5):421-2. PubMed ID: 11535008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemiparkinsonism and hemiatrophy syndrome: a rare observation.
    Tessitore A; Russo A; Cirillo M; Giordano A; Marcuccio L; Tedeschi G
    Clin Neurol Neurosurg; 2010 Jul; 112(6):524-6. PubMed ID: 20399008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients.
    Nevrly M; Kanovsky P; Vranova H; Langova K; Hlustik P
    Parkinsonism Relat Disord; 2009 Jul; 15(6):477-8. PubMed ID: 19028438
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long chronic course of hemiparkinson-plus with l-dopa maintained response].
    Arias M; Requena I; Lema C
    Rev Neurol; 1998 Jul; 27(155):94-5. PubMed ID: 9674037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty.
    Bonci A; Singh V
    Ann Neurol; 2006 May; 59(5):733-4. PubMed ID: 16634013
    [No Abstract]   [Full Text] [Related]  

  • 36. [Levodopa-responsive parkinsonism-dystonia due to a traumatic injury of the substantia nigra].
    Pérez Errazquin F; Gomez Heredia MJ
    Neurologia; 2012 Apr; 27(3):181-3. PubMed ID: 21570743
    [No Abstract]   [Full Text] [Related]  

  • 37. "Reversible" Alzheimer's disease?
    Peter F; Susanne J; Margareta H; Silvia W; Wolfgang K; Thomas L; Heinz TK
    J Am Geriatr Soc; 2011 Jun; 59(6):1137-8. PubMed ID: 21668917
    [No Abstract]   [Full Text] [Related]  

  • 38. [Are restless legs an indication in the treatment with levodopa?].
    Starzmann S
    Lakartidningen; 1999 Jul; 96(28-29):3238. PubMed ID: 10434504
    [No Abstract]   [Full Text] [Related]  

  • 39. [Syndrome of myatrophic ataxia].
    Lange E; Kulawik H; Kunath B
    Psychiatr Neurol Med Psychol (Leipz); 1972 Apr; 24(4):177-88. PubMed ID: 5050809
    [No Abstract]   [Full Text] [Related]  

  • 40. CYP2D6 gene polymorphism as a probable risk factor for Alzheimer's disease and Parkinson's disease with dementia.
    Gołab-Janowska M; Honczarenko K; Gawrońska-Szklarz B; Potemkowski A
    Neurol Neurochir Pol; 2007; 41(2):113-21. PubMed ID: 17530572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.